GemGem Therapeutics is building a world where children with motor challenges can access joyful, daily rehabilitation that strengthens their hand function and confidence. The company uses AI-powered digital therapy to turn clinically grounded hand training into play, enabling children with cerebral palsy and developmental delays to complete 400+ movements a day through camera-based computer vision. The core program, GemGem400, shows strong early traction with a 94.5% monthly renewal rate, a 45% conversion rate, and consistent functional gains reported by parents and therapists. Through IRB-approved clinical studies and upcoming US pilots, GemGem is creating an accessible, affordable global rehabilitation pathway for underserved families.
